4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -140,109 | -160,868 | -100,837 | -107,494 | -71,317 |
| Depreciation Amortization | -40 | -2,529 | 2,960 | 3,462 | 2,242 |
| Accounts receivable | N/A | N/A | N/A | 47 | 1,439 |
| Accounts payable and accrued liabilities | 6,773 | 871 | 896 | -1,638 | 2,285 |
| Other Working Capital | 6,172 | 537 | 630 | -1,336 | -15,534 |
| Other Operating Activity | 18,122 | 27,404 | 20,559 | 20,274 | 11,751 |
| Operating Cash Flow | $-109,082 | $-134,585 | $-75,792 | $-86,685 | $-69,134 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -536 | -3,786 | -2,771 | -11,536 | -9,110 |
| Purchase Of Investment | -442,821 | -467,652 | -54,802 | -153,313 | -168,570 |
| Sale Of Investment | 350,384 | 169,001 | 173,290 | 147,799 | 5,000 |
| Investing Cash Flow | $-92,973 | $-302,437 | $115,717 | $-17,050 | $-172,680 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 19,420 | 337,250 | 156,832 | 3,553 | 118,089 |
| Other Financing Activity | 93,540 | 0 | 0 | -468 | 0 |
| Financing Cash Flow | $112,960 | $337,250 | $156,832 | $3,085 | $118,089 |
| Beginning Cash Position | 149,336 | 249,108 | 52,351 | 153,001 | 276,726 |
| End Cash Position | 60,241 | 149,336 | 249,108 | 52,351 | 153,001 |
| Net Cash Flow | $-89,095 | $-99,772 | $196,757 | $-100,650 | $-123,725 |
| Free Cash Flow | |||||
| Operating Cash Flow | -109,082 | -134,585 | -75,792 | -86,685 | -69,134 |
| Capital Expenditure | -536 | -3,786 | -2,771 | -11,536 | -9,110 |
| Free Cash Flow | -109,618 | -138,371 | -78,563 | -98,221 | -78,244 |